Your browser doesn't support javascript.
loading
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma.
Liu, Jia-Xin; Liu, Xin; Yang, Yong; Liu, Wei-Ping; Wang, Ying; He, Xia; Zhang, Li-Ling; Qu, Bao-Lin; Qian, Li-Ting; Hou, Xiao-Rong; Qiao, Xue-Ying; Wang, Hua; Li, Gao-Feng; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Zhang, Hui-Lai; Su, Hang; Zhang, Yu-Jing; Zhu, Jun; Qi, Shu-Nan; Li, Ye-Xiong; Song, Yu-Qin.
Afiliación
  • Liu JX; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China.
  • Liu X; National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC); Center for Cancer Precision Medicine, CAMS and PUMC, National Institute of Biological Sciences, Collaborative Innovation Center for Cancer Medicine, Beijing, People's Republic
  • Yang Y; Fujian Medical University Union Hospital, Fuzhou, China.
  • Liu WP; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China.
  • Wang Y; Chongqing University Cancer Hospital & Chongqing Cancer Hospital, Chongqing, China.
  • He X; Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China.
  • Zhang LL; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Qu BL; The General Hospital of Chinese People's Liberation Army, Beijing, China.
  • Qian LT; The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Hou XR; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China.
  • Qiao XY; The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Wang H; Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Li GF; National Geriatric Medical Center, Beijing Hospital, Beijing, China.
  • Zhu Y; Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Zhejiang, Hangzhou, China.
  • Cao JZ; Shanxi Cancer Hospital and the Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
  • Wu JX; Fujian Provincial Cancer Hospital, Fuzhou, Fujian, China.
  • Wu T; Affiliated Hospital of Guizhou Medical University, Guizhou Cancer Hospital, Guiyang, Guizhou, China.
  • Zhu SY; Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, Hunan, China.
  • Shi M; Xijing Hospital of Fourth Military Medical University, Xi'an, China.
  • Zhang HL; Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
  • Su H; The Fifth Medical Center of PLA General Hospital, Beijing, China.
  • Zhang YJ; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Zhu J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China.
  • Qi SN; National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC); Center for Cancer Precision Medicine, CAMS and PUMC, National Institute of Biological Sciences, Collaborative Innovation Center for Cancer Medicine, Beijing, People's Republic
  • Li YX; National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC); Center for Cancer Precision Medicine, CAMS and PUMC, National Institute of Biological Sciences, Collaborative Innovation Center for Cancer Medicine, Beijing, People's Republic
  • Song YQ; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China.
Cancer Rep (Hoboken) ; 6(5): e1800, 2023 05.
Article en En | MEDLINE | ID: mdl-36919649
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma Extranodal de Células NK-T / Neoplasias Gastrointestinales Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Cancer Rep (Hoboken) Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma Extranodal de Células NK-T / Neoplasias Gastrointestinales Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Cancer Rep (Hoboken) Año: 2023 Tipo del documento: Article